Kalvista Other Assets from 2010 to 2024

KALV Stock  USD 9.32  0.36  4.02%   
Kalvista Pharmaceuticals Other Assets yearly trend continues to be fairly stable with very little volatility. Other Assets are likely to outpace its year average in 2024. During the period from 2010 to 2024, Kalvista Pharmaceuticals Other Assets regression line of quarterly data had mean square error of 324.1 B and geometric mean of 0.00. View All Fundamentals
 
Other Assets  
First Reported
2015-01-31
Previous Quarter
0.0
Current Value
1
Quarterly Volatility
170.2 K
 
Yuan Drop
 
Covid
Check Kalvista Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kalvista Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 424 K, Interest Expense of 0.0 or Selling General Administrative of 4.9 M, as well as many indicators such as Price To Sales Ratio of 46.33, Dividend Yield of 0.0 or Days Sales Outstanding of 268. Kalvista financial statements analysis is a perfect complement when working with Kalvista Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Kalvista Pharmaceuticals Correlation against competitors.
For more information on how to buy Kalvista Stock please use our How to Invest in Kalvista Pharmaceuticals guide.

Latest Kalvista Pharmaceuticals' Other Assets Growth Pattern

Below is the plot of the Other Assets of Kalvista Pharmaceuticals over the last few years. It is Kalvista Pharmaceuticals' Other Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kalvista Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Other Assets10 Years Trend
Very volatile
   Other Assets   
       Timeline  

Kalvista Other Assets Regression Statistics

Arithmetic Mean328,400
Geometric Mean0.00
Coefficient Of Variation167.06
Mean Deviation396,507
Median50,000
Standard Deviation548,640
Sample Variance301B
Range1.9M
R-Value(0.01)
Mean Square Error324.1B
R-Squared0.000064
Significance0.98
Slope(982.10)
Total Sum of Squares4.2T

Kalvista Other Assets History

2022 1.0
2021193 K
2020null
2019178 K
2017173 K
2015M
20141.9 M

About Kalvista Pharmaceuticals Financial Statements

Kalvista Pharmaceuticals investors use historical fundamental indicators, such as Kalvista Pharmaceuticals' Other Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Kalvista Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Assets 1.00  1,041,000 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Kalvista Stock Analysis

When running Kalvista Pharmaceuticals' price analysis, check to measure Kalvista Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalvista Pharmaceuticals is operating at the current time. Most of Kalvista Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kalvista Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalvista Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kalvista Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.